Re: 'Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients' by Fiolet et al

Clin Microbiol Infect. 2021 Jan;27(1):134-135. doi: 10.1016/j.cmi.2020.09.027. Epub 2020 Sep 25.

Authors

Alexis Lacout¹, Pierre Yves Marcy², Christian Perronne³

Affiliations

¹ Centre de Diagnostic, ELSAN, Centre Médico-Chirurgical, 83 avenue Charles de Gaulle, 15000 Aurillac, France. Electronic address: lacout.alexis@wanadoo.fr.
² Radiodiagnostics and Interventional Radiology Department, ELSAN, Polyclinique Les Fleurs, Quartier Quiez, 83190 Ollioules, France.
³ Infectious Diseases Unit, University Hospital Raymond Poincaré, APHP Versailles Saint Quentin University Garches, France.

No abstract available

Publication types

Letter
Comment

MeSH terms

Azithromycin* / therapeutic use
COVID-19*
Drug Therapy, Combination
Hospitalization
Humans
Hydroxychloroquine / therapeutic use
SARS-CoV-2

Substances

Hydroxychloroquine
Azithromycin